Skip to content
lifestyle.socialsinsider.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Xilio Therapeutics, Inc.
Xilio Therapeutics to Present New Preclinical Data for its Masked T Cell Engager Program Targeting CLDN18.2 at the American Association for Cancer Research (AACR) Annual Meeting
May 20, 2026
Xilio Therapeutics Announces 1-for-14 Reverse Stock Split
April 29, 2026
Xilio Therapeutics to Present at the Leerink Partners Global Healthcare Conference
March 2, 2026
←
Previous Page
1
2